Low Serum Levels of Alpha(1) Anti-trypsin (α(1)-AT) and Risk of Airflow Obstruction in Non-Primary α(1)-AT-Deficient Patients with Compensated Chronic Liver Disease

BACKGROUND: Alpha(1) anti-trypsin (α(1)-AT), a serine protease inhibitor synthesized in the liver, is a major circulating antiprotease that provides defense against proteolytic damage in several tissues. Its deficiency is associated with airflow obstruction. The present study aimed to explore the ro...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Romero, Elizabeth, Suárez-Cuenca, Juan Antonio, Elizalde-Barrera, César Iván, Mondragón-Terán, Paul, Martínez-Hernández, José Enrique, Gómez-Cortés, Eduardo, de Vaca, Rebeca Pérez-Cabeza, Hernández-Muñoz, Rolando E., Melchor-López, Alberto, Jiménez-Saab, Nayeli Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2015
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424928/
https://www.ncbi.nlm.nih.gov/pubmed/25913248
http://dx.doi.org/10.12659/MSM.893350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424928/
https://www.ncbi.nlm.nih.gov/pubmed/25913248
http://dx.doi.org/10.12659/MSM.893350

Ejemplares similares